Agonists or antagonists of CTACK or Vic chemokines, and various methods of
use in dermatological and related applications are provided. In
particular, the method makes use of fact that the CTACK or Vic chemokines
are specifically capable of inducing movement of a skin cell subset.
Moreover, matching of ligand with GPR2 receptor in mammals provides
methods of use.
